International Journal of Radiation Oncology * Biology * Physics
Volume 76, Issue 2 , Pages 477-484 , 1 February 2010

A Prospective Randomized Trial to Study the Impact of Pretreatment FDG-PET for Cervical Cancer Patients With MRI-Detected Positive Pelvic but Negative Para-Aortic Lymphadenopathy

Presented at the 48th Annual Meeting of the American Society for Therapeutic Radiology and Oncology, Philadelphia, PA, USA, Nov 5–9, 2006.

  • Chien-Sheng Tsai, M.D.

      Affiliations

    • Department of Radiation Oncology, Chang Gung Memorial Hospital and Chang Gung University, Taoyuan, Taiwan
    • Department of Medical Imaging and Radiological Science, Chang Gung University, School of Medicine, Taoyuan, Taiwan
    • ,
  • Chyong-Huey Lai, M.D.

      Affiliations

    • Department of Obstetrics and Gynecology, Chang Gung Memorial Hospital and Chang Gung University, Taoyuan, Taiwan
    • ,
  • Ting-Chang Chang, M.D.

      Affiliations

    • Department of Obstetrics and Gynecology, Chang Gung Memorial Hospital and Chang Gung University, Taoyuan, Taiwan
    • ,
  • Tzu-Chen Yen, M.D.

      Affiliations

    • Department of Nuclear Medicine, Chang Gung Memorial Hospital and Chang Gung University, Taoyuan, Taiwan
    • ,
  • Koon-Kwan Ng, M.D.

      Affiliations

    • Department of Diagnostic Radiology, Chang Gung Memorial Hospital and Chang Gung University, Taoyuan, Taiwan
    • ,
  • Swei Hsueh, M.D.

      Affiliations

    • Department of Pathology, Chang Gung Memorial Hospital and Chang Gung University, Taoyuan, Taiwan
    • ,
  • Steve P. Lee, M.D., Ph.D.

      Affiliations

    • Department of Radiation Oncology, University of California, Los Angeles, CA
    • ,
  • Ji-Hong Hong, M.D., Ph.D.

      Affiliations

    • Department of Radiation Oncology, Chang Gung Memorial Hospital and Chang Gung University, Taoyuan, Taiwan
    • Department of Medical Imaging and Radiological Science, Chang Gung University, School of Medicine, Taoyuan, Taiwan
    • Corresponding Author InformationReprint requests to: Ji-Hong Hong, M.D. Ph.D., Department of Radiation Oncology, Chung Gung Memorial Hospital, #5, Fu-Shin St., KweiShan, Taoyuan, Taiwan, R.O.C. Tel: (886) 3-3282177; Fax: (886) 3-3280797

Received 4 July 2008 ,Revised 17 December 2008 ,Accepted 9 February 2009.

References 

  1. Hong JH, Tsai CS, Chang JT, et al. The prognostic significance of pre- and posttreatment SCC levels in patients with squamous cell carcinoma of the cervix treated by radiotherapy. Int J Radiat Oncol Biol Phys. 1998;41:823–830
  2. Hong JH, Tsai CS, Lai CH, et al. Risk stratification of patients with advanced squamous cell carcinoma of cervix treated by radiotherapy alone. Int J Radiat Oncol Biol Phys. 2005;63:492–499
  3. Kapp KS, Stuecklschweiger GF, Kapp DS, et al. Prognostic factors in patients with carcinoma of the uterine cervix treated with external beam irradiation and IR-192 high-dose-rate brachytherapy. Int J Radiat Oncol Biol Phys. 1998;42:531–540
  4. Toita T, Kakinohana Y, Shinzato S, et al. Tumor diameter/volume and pelvic node status assessed by magnetic resonance imaging (MRI) for uterine cervical cancer treated with irradiation. Int J Radiat Oncol Biol Phys. 1999;43:777–782
  5. Barillot I, Horiot JC, Pigneux J, et al. Carcinoma of the intact uterine cervix treated with radiotherapy alone: A French cooperative study: update and multivariate analysis of prognostics factors. Int J Radiat Oncol Biol Phys. 1997;38:969–978
  6. Tsai CS, Lai CH, Wang CC, et al. The prognostic factors for patients with early cervical cancer treated by radical hysterectomy and postoperative radiotherapy. Gynecol Oncol. 1999;75:328–333
  7. Chatani M, Matayoshi Y, Masaki N, et al. Prophylactic irradiation of para-aortic lymph nodes in carcinoma of the uterine cervix. A prospective randomized study. Strahlenther Onkol. 1995;171:655–660
  8. Haie C, Pejovic MH, Gerbaulet A, et al. Is prophylactic para-aortic irradiation worthwhile in the treatment of advanced cervical carcinoma? Results of a controlled clinical trial of the EORTC radiotherapy group. Radiother Oncol. 1988;11:101–112
  9. Rotman M, Pajak TF, Choi K, et al. Prophylactic extended-field irradiation of para-aortic lymph nodes in stages IIB and bulky IB and IIA cervical carcinomas. Ten-year treatment results of RTOG 79-20. JAMA. 1995;274:387–393
  10. Grigsby PW, Heydon K, Mutch DG, et al. Long-term follow-up of RTOG 92-10: Cervical cancer with positive para-aortic lymph nodes. Int J Radiat Oncol Biol Phys. 2001;51:982–987
  11. Small W, Winter K, Levenback C, et al. Extended-field irradiation and intracavitary brachytherapy combined with cisplatin chemotherapy for cervical cancer with positive para-aortic or high common iliac lymph nodes: Results of ARM 1 of RTOG 0116. Int J Radiat Oncol Biol Phys. 2007;68:1081–1087
  12. Rose PG, Adler LP, Rodriguez M, et al. Positron emission tomography for evaluating para-aortic nodal metastasis in locally advanced cervical cancer before surgical staging: A surgicopathologic study. J Clin Oncol. 1999;17:41–45
  13. Reinhardt MJ, Ehritt-Braun C, Vogelgesang D, et al. Metastatic lymph nodes in patients with cervical cancer: detection with MR imaging and FDG PET. Radiology. 2001;218:776–782
  14. Lin WC, Hung YC, Yeh LS, et al. Usefulness of (18)F-fluorodeoxyglucose positron emission tomography to detect para-aortic lymph nodal metastasis in advanced cervical cancer with negative computed tomography findings. Gynecol Oncol. 2003;89:73–76
  15. Sironi S, Buda A, Picchio M, et al. Lymph node metastasis in patients with clinical early-stage cervical cancer: Detection with integrated FDG PET/CT. Radiology. 2006;238:272–279
  16. Grigsby PW, Siegel BA, Dehdashti F. Lymph node staging by positron emission tomography in patients with carcinoma of the cervix. J Clin Oncol. 2001;19:3745–3749
  17. Tsai CS, Chang TC, Lai CH, et al. Preliminary report of using FDG-PET to detect extrapelvic lesions in cervical cancer patients with enlarged pelvic lymph nodes on MRI/CT. Int J Radiat Oncol Biol Phys. 2004;58:1506–1512
  18. Chang TC, Law KS, Hong JH, et al. Positron emission tomography for unexplained elevation of serum squamous cell carcinoma antigen levels during follow-up for patients with cervical malignancies: a phase II study. Cancer. 2004;101:164–171
  19. Yen TC, Ng KK, Ma SY, et al. Value of dual-phase 2-fluoro-2-deoxy-D-glucose positron emission tomography in cervical cancer. J Clin Oncol. 2003;21:3651–3658
  20. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc. 1958;53:457–481
  21. Hong J, Tsai C, Chang T, et al. An interim analysis of a phase III randomized trial of using FDG-PET in the management of cervical cancer patients with positive pelvic node on MRI image. Int J Radiat Oncol Biol Phys. 2006;66(Suppl):S163
  22. Miller TR, Grigsby PW. Measurement of tumor volume by PET to evaluate prognosis in patients with advanced cervical cancer treated by radiation therapy. Int J Radiat Oncol Biol Phys. 2002;53:353–359
  23. Ma S-Y, See L-C, Lai C-H, et al. Delayed (18)F-FDG PET for detection of paraaortic lymph node metastases in cervical cancer patients. J Nucl Med. 2003;44:1775–1783
  24. Lin LL, Mutic S, Low DA, et al. Adaptive brachytherapy treatment planning for cervical cancer using FDG-PET. Int J Radiat Oncol Biol Phys. 2007;67:91–96
  25. Lin LL, Yang Z, Mutic S, et al. FDG-PET imaging for the assessment of physiologic volume response during radiotherapy in cervix cancer. Int J Radiat Oncol Biol Phys. 2006;65:177–181
  26. Grigsby PW, Siegel BA, Dehdashti F, et al. Posttherapy [18F] fluorodeoxyglucose positron emission tomography in carcinoma of the cervix: Response and outcome. J Clin Oncol. 2004;22:2167–2171
  27. Schwarz JK, Siegel BA, Dehdashti F, et al. Association of posttherapy positron emission tomography with tumor response and survival in cervical carcinoma. JAMA. 2007;298:2289–2295
  28. Carey BP, Coleman RE, Grigsby PW, et al. Medicare coverage of PET for cervical cancer. J Am Coll Radiol. 2006;3:19–22
  29. Boffetta P, Parkin DM. Cancer in developing countries. CA Cancer J Clin. 1994;44:81–90
  30. Sankaranarayanan R. Overview of cervical cancer in the developing world. FIGO 6th Annual Report on the Results of Treatment in Gynecological Cancer. Int J Gynaecol Obstet. 2006;95(Suppl 1):S205–S210
  31. Grigsby PW, Singh AK, Siegel BA, et al. Lymph node control in cervical cancer. Int J Radiat Oncol Biol Phys. 2004;59:706–712
  32. Grigsby PW, Mutch DG, Rader J, et al. Lack of benefit of concurrent chemotherapy in patients with cervical cancer and negative lymph nodes by FDG-PET. Int J Radiat Oncol Biol Phys. 2005;61:444–449
  33. Lai CH, Huang KG, Hong JH, et al. Randomized trial of surgical staging (extraperitoneal or laparoscopic) versus clinical staging in locally advanced cervical cancer. Gynecol Oncol. 2003;89:160–167
  34. Choi HJ, Roh JW, Seo SS, et al. Comparison of the accuracy of magnetic resonance imaging and positron emission tomography/computed tomography in the presurgical detection of lymph node metastases in patients with uterine cervical carcinoma: A prospective study. Cancer. 2006;106:914–922
  35. Wright JD, Dehdashti F, Herzog TJ, et al. Preoperative lymph node staging of early-stage cervical carcinoma by [18F]-fluoro-2-deoxy-D-glucose-positron emission tomography. Cancer. 2005;104:2484–2491
  36. Loft A, Berthelsen AK, Roed H, et al. The diagnostic value of PET/CT scanning in patients with cervical cancer: A prospective study. Gynecol Oncol. 2007;106:29–34

 Note—An online CME test for this article can be taken at http://asro.astro.org under Continuing Education.

 Supported by Grants CMRPG32024 from Chang Gung Memorial Hospital and NSC93-2314-B-182A-127 from National Science Council, Taiwan.

 Conflict of interest: none.

PII: S0360-3016(09)00259-4

doi: 10.1016/j.ijrobp.2009.02.020

International Journal of Radiation Oncology * Biology * Physics
Volume 76, Issue 2 , Pages 477-484 , 1 February 2010

Article Tools

* Image Usage & Resolution